help button home button The Oncologist
HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
The Oncologist, Vol. 12, No. suppl_1, 43-51, May 2007; doi:10.1634/theoncologist.12-S1-43
© 2007 AlphaMed Press

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow eLetters: Submit a response to this article
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Reprints/Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Carroll, J. K.
Right arrow Articles by Morrow, G. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Carroll, J. K.
Right arrow Articles by Morrow, G. R.

Pharmacologic Treatment of Cancer-Related Fatigue

Jennifer K. Carrolla,b, Sadhna Kohlia,c, Karen M. Mustiana, Joseph A. Roscoea, Gary R. Morrowa,d

aDepartment of Radiation Oncology, bDepartment of Family Medicine, cDepartment of Medicine, and dDepartment of Psychiatry, University of Rochester School of Medicine and Destistry, James P. Wilmot Cancer Center, Rochester, New York, USA

Key Words. Cancer • Fatigue • Hematopoietic • Corticosteroids • Psychostimulants

Correspondence: Jennifer Carroll, M.D., M.P.H., Department of Family Medicine, University of Rochester School of Medicine, Family Medicine Research Programs, 1381 South Avenue, Rochester, New York 14620, USA. Telephone: 585-506-9484 ext. 219; Fax: 585-473-2245; e-mail: Jennifer_Carroll{at}URMC.Rochester.edu

Fatigue is the most commonly reported symptom in patients with cancer, with a prevalence of over 60% reported in the majority of studies. This paper systematically reviews pharmacologic agents in the treatment of cancer-related fatigue (CRF). We conducted a literature review of clinical trials that assessed pharmacologic agents for the treatment of CRF. These agents include hematopoietics (for anemia), corticosteroids, and psychostimulants. Other therapeutic agents that are less well studied for CRF but are currently the focus of clinical trials include L-carnitine, modafinil, bupropion, and selective serotonin reuptake inhibitors such as paroxetine.

Disclosure of potential conflicts of interest is found at the end of this article.




This article has been cited by other articles:


Home page
 The OncologistHome page
G. R. Morrow
Cancer-Related Fatigue: Causes, Consequences, and Management
Oncologist, May 1, 2007; 12(suppl_1): 1 - 3.
[Abstract] [Full Text] [PDF]

Home page
 The OncologistHome page
K. M. Mustian, G. R. Morrow, J. K. Carroll, C. D. Figueroa-Moseley, P. Jean-Pierre, and G. C. Williams
Integrative Nonpharmacologic Behavioral Interventions for the Management of Cancer-Related Fatigue
Oncologist, May 1, 2007; 12(suppl_1): 52 - 67.
[Abstract] [Full Text] [PDF]


HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
THE ONCOLOGIST STEM CELLS CME ALPHAMED PRESS JOURNALS


Copyright © 2007 by AlphaMed Press.